XIAOGAN SHI LIHENG TRADING CO., LTD. – Trademark Portfolio
Entity Type: 99
XIAOGAN SHI LIHENG TRADING CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SANOVIST and WIXOLYTRA. The owner is based in XIAO GAN.
ROOM 2507, 25TH FLOOR, BUILDING 5
WANLIUHUI III, TEYIHAO, DONGYONG ROAD
XIAO GAN 432009 , CN
Showing of trademarks Trademarks
Trademark Classifications
XIAOGAN SHI LIHENG TRADING CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does XIAOGAN SHI LIHENG TRADING CO., LTD. have?
XIAOGAN SHI LIHENG TRADING CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does XIAOGAN SHI LIHENG TRADING CO., LTD. file in?
XIAOGAN SHI LIHENG TRADING CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are XIAOGAN SHI LIHENG TRADING CO., LTD.'s most well-known trademarks?
XIAOGAN SHI LIHENG TRADING CO., LTD.'s registered trademark portfolio includes well-known marks such as SANOVIST and WIXOLYTRA. These are among 2 currently registered trademarks in the portfolio.
What is XIAOGAN SHI LIHENG TRADING CO., LTD.'s trademark registration success rate?
XIAOGAN SHI LIHENG TRADING CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.